Brief: H. Lundbeck Announces Positive Results From RESOLUTION Trial
03/12/2024 07:12
Dec 3 (Reuters) - H Lundbeck A/S HLUNb.CO :
* EFFICACY OF VYEPTI HIGHLIGHTED BY NEW CLINICAL TRIAL
RESULTS IN
SEVERE MIGRAINE
* - VYEPTI MET PRIMARY ENDPOINT, SHOWING STATISTICALLY
SIGNIFICANT
GREATER MONTHLY MIGRAINE DAY (MMD) REDUCTIONS
Source text: ID:nWkr6NsSCk
Further company coverage: HLUNb.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))